Luteinizing Hormone and Ovarian Stimulation for In-Vitro Fertilization: Do Science and Business Always Agree?
Luteinizing Hormone and Ovarian Stimulation for In-Vitro Fertilization: Do Science and Business Always Agree?
Review Data
Q: Is the topic relevant to the journal's area of interest? Is it contemporary and interesting for
researchers?
A: Good
Abstract & Keywords
Q: Are all required components included in the abstract? Are the keywords appropriately chosen?
A: Good
Goal
Q: Is the goal explicitly stated in the Introduction? Is its formulation clear and unambiguous?
A: Good
Structure
Q: Is the paper's structure coherent? Is it in coherence with the goal of the paper?
A: Good
Tools and Methods
Q: Are the methods the author uses adequate and well used?
A: Good
Discussion & Conclusion
Q: Is it related to the results presented before? Do you consider them as coherent?
A: Good
Comments: The manuscript discussed the product composition of human menopausal gonadotropin, GnRH analogues, GnRH antagonists and recombinant LH. Further, the commentary described population-based randomized controlled trial (RCT)’s and patients who can benefit from LH supplementation. Product development often results in financial and practical considerations, resulting in deviating from physiology. Lastly, the authors suggest that there is a need to revisit physiology and clinical thinking to individualize the treatment strategy as per the requirement of the “every-day” patients.
Literature
Q: Does the author utilize relevant literature?
A: Good
Author's knowledge
Q: What is the level of the author’s knowledge? Does the author utilize all recent contributions relevant to the topic?
A: Good
Length
Q: Is the paper's length adequate to the topic's significance? Do you suggest shortening the paper without losing its value?
A: Good
Figures & Tables
Q: Does the author use them suitably? Are legend and notations clear?
A: Good
Writing style
Q: Is it clear and understandable?
A: Good
Further comments on the paper
Comments: The manuscript gives a commentary on luteinizing hormone and ovarian stimulation for in-vitro fertilization. The paper mainly highlighted the association between business decisions and scientific development, followed by the major steps in the development of fertility medications. Further, the authors suggested that population-based studies may be replaced with studies on specific endocrine events that may expose the individual patient to transient LH deficiency and also illustrate the need for LH supplementation.
Q: Would you recommend this manuscript for further publication?
A: Yes - Suitable to be published
If you have any questions and clarifications you can write to the journal.
Thanks,
Science Repository Team
Science Repository This email is restricted to the intended user. |
Science Repository - Support |
Author Info
Corresponding Author
Shahar KolIVF Unit, Elisha Hospital, Haifa, Israel
Article Info
Article Type
CommentaryPublication history
Received: Sat 09, Jul 2022Accepted: Mon 25, Jul 2022
Published: Mon 22, Aug 2022
Copyright
© 2023 Shahar Kol. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Hosting by Science Repository.DOI: 10.31487/j.CEI.2022.01.01